Guardant Health company profile
Company profile
Guardant Health has 2,490 employees and is headquartered in Palo Alto, United States.
Founded in 2011 and based in Palo Alto, California, the company focuses on precision oncology, analyzing DNA from blood and tumor samples to support cancer care and research. Its Guardant360 tests profile tumors for clinicians, the Guardant Reveal test detects cancer through circulating tumor DNA, and the Shield blood test screens adults for colorectal cancer. For drug developers and biopharmaceutical customers it offers the GuardantINFINITY and GuardantOMNI assays, the GuardantConnect software, and development services that range from companion diagnostics to clinical study support and kit delivery. Its products reach customers in the United States and internationally.
In the fiscal year ended December 2025, revenue reached 982.0 million US dollars, up 32.9% from the previous year, while the net loss was 416.3 million US dollars. The United States generated 94% of revenue and other markets 6%. The company employed 2,490 people. It also works with Nuvalent, Inc. on oncology drug development.
Company facts
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Headquarters
- 3100 Hanover Street, 94304, Palo Alto
- Employees
- 2,490
- Chief executive
- Dr. Helmy Eltoukhy Ph.D.
- Founded
- 2011
- Fiscal year
- January - December
- Listing
- GH · NASDAQ
- Currency
- USD
- ISIN
- US40131M1099
- Website
- guardanthealth.com
Guardant Health and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Guardant HealthGH | United States | $20.52B | 2,490 | -39.4% | — |
| Medpace HoldingsMEDP | United States | $18.27B | 6,600 | 21.4% | 36.3 |
| RevvityRVTY | United States | $17.84B | 11,000 | 16.3% | 70.5 |
| Charles River Laboratories InternationalCRL | United States | $16.19B | 18,300 | 14.3% | 367.4 |
| Quest DiagnosticsDGX | United States | $28.85B | 60,000 | 14.9% | 26.1 |
| ICON PublicICLR | United States | $14.58B | 40,250 | 2.7% | 77.9 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
